Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
9.22
-2.95
-32.00%
Share Warrants & Outstandings
Total Reserve
4.76
5.43
-0.67
-12.34%
Shareholder's Funds
11.04
14.65
-3.61
-24.64%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
3.79
-1.53
-40.37%
Secured Loans
0.80
3.08
-2.28
-74.03%
Unsecured Loans
1.45
0.71
0.74
104.23%
Deferred Tax Assets / Liabilities
-0.02
0.91
-0.93
-102.20%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.80
-0.80
-100.00%
Total Non-Current Liabilities
2.39
5.50
-3.11
-56.55%
Current Liabilities
Trade Payables
5.97
33.61
-27.64
-82.24%
Other Current Liabilities
3.70
4.08
-0.38
-9.31%
Short Term Borrowings
5.00
36.26
-31.26
-86.21%
Short Term Provisions
0.00
0.44
-0.44
-100.00%
Total Current Liabilities
14.67
74.39
-59.72
-80.28%
Total Liabilities
28.10
94.54
-66.44
-70.28%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
50.69
-49.59
-97.83%
Less: Accumulated Depreciation
0.14
25.23
-25.09
-99.45%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
25.46
-24.50
-96.23%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.21
-0.21
-100.00%
Long Term Loans & Advances
0.00
0.67
-0.67
-100.00%
Other Non Current Assets
0.00
0.81
-0.81
-100.00%
Total Non-Current Assets
0.96
27.15
-26.19
-96.46%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
49.97
-49.25
-98.56%
Sundry Debtors
24.55
13.25
11.30
85.28%
Cash and Bank
0.20
0.67
-0.47
-70.15%
Other Current Assets
0.14
1.72
-1.58
-91.86%
Short Term Loans and Advances
1.55
1.79
-0.24
-13.41%
Total Current Assets
27.15
67.39
-40.24
-59.71%
Net Current Assets (Including Current Investments)
12.47
-7.00
19.47
278.14%
Total Current Assets Excluding Current Investments
27.15
67.39
-40.24
-59.71%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
94.54
-66.44
-70.28%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
40.05
-32.79
-81.87%
Book Value per share (adjusted)
17.60
15.89
1.71
10.76%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
